Clinical experience with dihydroxyphenylalanine (DOPA) in depression
- 1 December 1963
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 1 (4), 289-297
- https://doi.org/10.1016/0022-3956(63)90004-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- BIOCHEMICAL AND PRESSOR EFFECTS OF ORAL d, l‐DIHYDROXYPHENYLALANINE IN PATIENTS PRETREATED WITH ANTIDEPRESSANT DRUGS *Annals of the New York Academy of Sciences, 1963
- Dihydroxyphenylalanine in Extrapyramidal DiseasePublished by American Medical Association (AMA) ,1963
- Dopamine metabolism in Parkinson's diseaseNeurology, 1963
- Biochemistry of Parkinson's diseaseNeurology, 1963
- NEW DEVELOPMENTS IN METABOLISM OF MESCALINE AND RELATED AMINES *Annals of the New York Academy of Sciences, 1962
- THE METABOLISM OF DIHYDROXYPHENYLALANINE IN MAN BEFORE AND AFTER ADMINISTRATION OF PSYCHOTROPIC DRUGS *Annals of the New York Academy of Sciences, 1962
- Effects of Amino Acid Feedings in Schizophrenic Patients Treated with IproniazidScience, 1961
- A CLINICAL AND BIOCHEMICAL STUDY OF A TRIAL OF IPRONIAZID IN THE TREATMENT OF DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1959
- 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine AntagonistsNature, 1957
- A CONCEPT FOR A ROLE OF SEROTONIN AND NOREPINEPHRINE AS CHEMICAL MEDIATORS IN THE BRAINAnnals of the New York Academy of Sciences, 1957